Here are six updates on GI companies from the past week:
GI & Endoscopy
AmSurg honored 45 ASCs as AmSurg Innovators at its annual Center Leadership Conference, Oct. 4 to Oct. 6 in Nashville, Tenn.
A study, published in the Indian Journal of Gastroenterology, examined the safety and efficacy of Mederi Therapeutics' Stretta Therapy in treating gastroesophageal reflux disease.
A survey, performed by the American Gastroenterological Association, examined how consumers manage pain using over-the-counter medication.
Vizient bestowed its 2017 Innovative Technology designation on Teleflex's LMA Gastro Airway medical device.
Clark Harrison, MD, is a gastroenterologist at Gastroenterology Consultants in Reno, Nev.
Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Oct. 30 to Nov. 3.
A study, published in JAMA Oncology, examined how the ACA's implementation impacted colorectal cancer screening.
Studies, presented at the 25th UEG Week, demonstrated the effectiveness of Takeda's Entyvio in treating ulcerative colitis and Crohn's disease, IBD News Today reports.
The Inquirer recognized Noel Fajardo, MD, during the seventh annual The Outstanding Filipinos in America awards in New York City.
